Hence, a tentative explanation may be given as that the B-cell ST6Gal-1 level increases along with a higher disease activity by chronic antigen exposure (eventually proceeds with increased cell and IgG sialylation) in SLE and RA. This evidence concerns the gene ST6GAL1 and rheumatoid arthritis.